Eyepoint Pharmaceuticals Earnings Estimate
EYPT Stock | USD 7.68 0.26 3.27% |
Eyepoint Pharmaceuticals Revenue Breakdown by Earning Segment
By analyzing Eyepoint Pharmaceuticals' earnings estimates, investors can diagnose different trends across Eyepoint Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Eyepoint Pharmaceuticals' Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.94 in 2024, whereas Pretax Profit Margin is likely to drop (1.61) in 2024.
Eyepoint |
Eyepoint Pharmaceuticals Earnings per Share Projection vs Actual
About Eyepoint Pharmaceuticals Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Eyepoint Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Eyepoint Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Eyepoint Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Last Reported | Projected for Next Year | ||
Retained Earnings | -742.1 M | -705 M | |
Retained Earnings Total Equity | -604.2 M | -634.4 M | |
Earnings Yield | (0.08) | (0.08) | |
Price Earnings Ratio | (12.38) | (12.99) | |
Price Earnings To Growth Ratio | 0.27 | 0.31 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.